Literature DB >> 3237504

Cardiomyopathy of Duchenne muscular dystrophy.

L D'Orsogna1, J P O'Shea, G Miller.   

Abstract

A total of 18 male patients with Duchenne muscular dystrophy (DMD), aged 8-29 years (mean, 15.7 years), were prospectively studied to assess the cardiomyopathy associated with DMD, using clinical parameters and noninvasive cardiovascular investigations: electrocardiogram (ECG), Holter monitoring, and echocardiography. In addition, five clinical tests of cardiovascular autonomic function were used to assess the role of the autonomic nervous system in the pathogenesis of dysrhythmias. The majority of subjects were asymptomatic, but four had abnormal physical findings. All had abnormal ECG, the commonest abnormality (in 16) being tall R waves or increased R/S ratios in the right precordial leads; 14 had abnormal findings on echocardiography, including three with poor left ventricular function and five with mitral valve prolapse (MVP). Labile abrupt sinus tachycardia was present in 11, and four had high-grade ventricular ectopy. None had definite clinical evidence of autonomic dysfunction. The cardiomyopathy of DMD appears to be unrelated to disease severity. However, abnormal Q waves or Q/R ratios in ECG leads I, aVL9 and V5-V6 are significantly related to young age (p less than 0.05), and high-grade ventricular ectopy occurred significantly more frequently (p less than 0.05) in older subjects (greater than 15 years). Dysrhythmias were not related to the presence of MVP, poor left ventricular function, or autonomic dysfunction.

Entities:  

Mesh:

Year:  1988        PMID: 3237504     DOI: 10.1007/BF02078410

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  29 in total

1.  Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy.

Authors:  J GILROY; J L CAHALAN; R BERMAN; M NEWMAN
Journal:  Circulation       Date:  1963-04       Impact factor: 29.690

2.  Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy.

Authors:  T N JAMES
Journal:  Am Heart J       Date:  1962-01       Impact factor: 4.749

3.  Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases.

Authors:  C A SWINYARD; G G DEAVER; L GREENSPAN
Journal:  Arch Phys Med Rehabil       Date:  1957-09       Impact factor: 3.966

4.  Pathogenesis of muscular dystrophies. Sympathetic neurovascular components.

Authors:  O Appenzeller; G Ogin
Journal:  Arch Neurol       Date:  1975-01

5.  Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients.

Authors:  J K Perloff
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

6.  Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests.

Authors:  R H Hunsaker; P K Fulkerson; F J Barry; R P Lewis; C V Leier; D V Unverferth
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

7.  Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy.

Authors:  H Nomura; K Hizawa
Journal:  Acta Pathol Jpn       Date:  1982-11

8.  Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging.

Authors:  J K Perloff; E Henze; H R Schelbert
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

9.  Tests for autonomic neuropathy in diabetic children.

Authors:  E A Mitchell; S R Wealthall; R B Elliott
Journal:  Aust Paediatr J       Date:  1985-05

10.  An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy.

Authors:  S K Sanyal; W W Johnson; M K Thapar; S E Pitner
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  15 in total

Review 1.  Arrhythmias in the muscular dystrophies.

Authors:  Archana Rajdev; William J Groh
Journal:  Card Electrophysiol Clin       Date:  2015-03-29

2.  Steroid therapy and cardiac function in Duchenne muscular dystrophy.

Authors:  L W Markham; R L Spicer; P R Khoury; B L Wong; K D Mathews; L H Cripe
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 3.  Cardiopulmonary support in duchenne muscular dystrophy.

Authors:  Josef Finsterer
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

4.  The heart in muscular dystrophy: an electrocardiographic and ultrasound study of 20 patients.

Authors:  P Berlit; B Stegaru-Hellring
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

5.  Suitable analyzed signal duration and criteria for abnormal signal-averaged electrocardiogram on frequency-domain analysis in patients with Duchenne's muscular dystrophy.

Authors:  M Kubo; S Matsuoka; Y Kuroda
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

6.  Clinical significance of late potential in patients with Duchenne muscular dystrophy.

Authors:  M Kubo; S Matsuoka; Y Taguchi; H Akita; Y Kuroda
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655

7.  Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.

Authors:  Venus Ameen; Lesley G Robson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

8.  Assessment of left ventricular regional function in affected and carrier dogs with Duchenne muscular dystrophy using speckle tracking echocardiography.

Authors:  Hiroshi Takano; Yoko Fujii; Naoko Yugeta; Shinichi Takeda; Yoshito Wakao
Journal:  BMC Cardiovasc Disord       Date:  2011-05-25       Impact factor: 2.298

9.  Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.

Authors:  Naoko Yugeta; Nobuyuki Urasawa; Yoko Fujii; Madoka Yoshimura; Katsutoshi Yuasa; Michiko R Wada; Masao Nakura; Yoshiki Shimatsu; Masayuki Tomohiro; Akio Takahashi; Noboru Machida; Yoshito Wakao; Akinori Nakamura; Shin'ichi Takeda
Journal:  BMC Cardiovasc Disord       Date:  2006-12-04       Impact factor: 2.298

Review 10.  Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.

Authors:  Jacqueline N Robinson-Hamm; Charles A Gersbach
Journal:  Hum Genet       Date:  2016-08-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.